Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Epithelial ovarian cancer is mostly diagnosed at late stage (III/IV), and the standard
treatment for ovarian cancer includes primary debulking surgery and platinum-based adjuvant
chemotherapy. However, scholars suggest that neoadjuvant chemotherapy can be used to reduce
the tumor load and control the patient's condition. The aim of this study is to verify the
efficacy of primary debulking surgery versus neoadjuvant chemotherapy.